Learn to Customize Your Own Options Trading Strategy

From RJO Futures | Ad

This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.

Download your FREE Options Strategy Guide Today!

BMRN Insider Trading (BioMarin Pharmaceutical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.69%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,385,049.97

BioMarin Pharmaceutical Insider Trading History Chart

BioMarin Pharmaceutical Share Price & Price History

^$73.74

▼ -1.34 (-1.78%)

As of 10/22/2021 01:00 AM ET

Days: 30 | 90 | 365

Learn to Customize Your Own Options Trading Strategy

From RJO Futures | Ad

Download your FREE Options Strategy Guide Today!

BioMarin Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/10/2021	Jean Jacques Bienaime	CEO	Sell	8,513	$77.29	$657,969.77	312,352
5/7/2021	Brian R. Mueller	CFO	Sell	6,709	$79.50	$533,365.50	31,357
5/7/2021	Jean Jacques Bienaime	CEO	Sell	25,000	$78.12	$1,953,000.00	303,839
5/6/2021	Richard A. Meier	Director	Sell	5,068	$78.38	$397,229.84	99,340
5/3/2021	George Eric Davis	EVP	Sell	4,673	$78.30	$365,895.90	68,781
4/23/2021	Jean Jacques Bienaime	CEO	Sell	10,000	$79.34	$793,400.00	312,498
4/19/2021	George Eric Davis	EVP	Sell	2,709	$79.58	$215,582.22	71,149
4/8/2021	Jeffrey Robert Ajer	EVP	Sell	1,537	$78.81	$121,130.97	58,250
4/1/2021	Brian R. Mueller	CFO	Sell	5,692	$76.30	$434,299.60	31,016
3/24/2021	Jeffrey Robert Ajer	EVP	Sell	1,181	$76.30	$90,110.30	61,439
3/18/2021	Jeffrey Robert Ajer	EVP	Sell	1,308	$77.99	$102,010.92	64,133
3/11/2021	Jean Jacques Bienaime	CEO	Sell	7,000	$77.68	$543,760.00	295,652
3/5/2021	Michael G Grey	Director	Sell	5,000	$76.28	$381,400.00	47,840
2/19/2021	Jean Jacques Bienaime	CEO	Sell	7,000	$83.58	$585,060.00	302,552
2/17/2021	Jean Jacques Bienaime	CEO	Sell	8,000	$84.54	$676,320.00	303,552
1/29/2021	Jean Jacques Bienaime	CEO	Sell	8,334	$82.67	$688,971.78	303,885
1/27/2021	Jean Jacques Bienaime	CEO	Sell	8,333	$85.49	$712,388.17	303,885
12/28/2020	Jean Jacques Bienaime	CEO	Sell	1,500	$88.77	$133,155.00	297,052
10/14/2020	Jeffrey Robert Ajer	EVP	Sell	2,121	$79.91	$169,489.11	61,281
8/31/2020	David E I Pyott	Director	Buy	12,800	$78.26	$1,001,728.00	29,840
8/3/2020	Michael G Grey	Director	Sell	2,500	$120.35	$300,875.00	45,340
7/20/2020	Henry J Fuchs	Insider	Sell	126,389	$130.00	$16,430,570.00	104,245
7/13/2020	Henry J Fuchs	Insider	Sell	23,011	$130.00	$2,991,430.00	102,995
6/26/2020	Willard H Dere	Director	Sell	4,430	$123.61	$547,592.30	13,290
6/19/2020	Jeffrey Robert Ajer	EVP	Sell	15,000	$124.00	$1,860,000.00	63,402
6/5/2020	V Bryan Lawlis	Director	Sell	4,430	$107.46	$476,047.80	18,850
5/8/2020	Jean Jacques Bienaime	CEO	Sell	20,000	$91.72	$1,834,400.00	318,552
5/4/2020	Jean Jacques Bienaime	CEO	Sell	5,000	$88.00	$440,000.00	298,552
5/1/2020	George Eric Davis	EVP	Sell	12,504	$89.38	$1,117,607.52	78,181
5/1/2020	Jean Jacques Bienaime	CEO	Sell	4,000	$89.38	$357,520.00	298,552
4/28/2020	Jean Jacques Bienaime	CEO	Sell	20,000	$97.58	$1,951,600.00	318,213
4/24/2020	Henry J Fuchs	Insider	Sell	20,000	$95.88	$1,917,600.00	109,014
4/20/2020	Henry J Fuchs	Insider	Sell	17,213	$90.00	$1,549,170.00	122,656
4/9/2020	Jean Jacques Bienaime	CEO	Sell	10,000	$79.06	$790,600.00	308,213
4/8/2020	Jeffrey Robert Ajer	EVP	Sell	2,407	$79.98	$192,511.86	63,064
4/1/2020	Jeffrey Robert Ajer	EVP	Sell	1,537	$82.00	$126,034.00	65,471
3/24/2020	Jeffrey Robert Ajer	EVP	Sell	2,041	$74.36	$151,768.76	68,626
3/17/2020	V Bryan Lawlis	Director	Sell	3,750	$75.39	$282,712.50	18,980
3/9/2020	Jean Jacques Bienaime	CEO	Sell	10,000	$89.52	$895,200.00	296,443
1/14/2020	Jean Jacques Bienaime	CEO	Sell	8,000	$87.95	$703,600.00	335,530
1/7/2020	Jean Jacques Bienaime	CEO	Sell	3,000	$84.46	$253,380.00	330,530
12/27/2019	Jean Jacques Bienaime	CEO	Sell	5,000	$86.16	$430,800.00
12/17/2019	V Bryan Lawlis	Director	Sell	3,750	$83.36	$312,600.00	27,340
11/26/2019	George Eric Davis	EVP	Sell	3,190	$79.66	$254,115.40	68,709
11/22/2019	Jean Jacques Bienaime	CEO	Sell	10,000	$77.60	$776,000.00	327,070
10/25/2019	Jean Jacques Bienaime	CEO	Sell	5,000	$69.55	$347,750.00	332,520
9/17/2019	V Bryan Lawlis	Director	Sell	3,750	$74.47	$279,262.50	27,340
6/17/2019	V Bryan Lawlis	Director	Sell	3,750	$81.08	$304,050.00	27,340
5/10/2019	Jean Jacques Bienaime	CEO	Sell	10,000	$82.52	$825,200.00	336,520
5/8/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$82.16	$328,640.00	326,520
4/26/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$82.88	$248,640.00	329,211
4/12/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$89.12	$356,480.00	325,211
4/8/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$91.87	$275,610.00	327,211
4/5/2019	Brian R. Mueller	SVP	Sell	2,953	$94.00	$277,582.00	13,660
4/5/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$93.37	$280,110.00	327,211
4/1/2019	Daniel K Spiegelman	CFO	Sell	13,473	$89.00	$1,199,097.00	47,510
3/27/2019	Daniel K Spiegelman	CFO	Sell	100	$90.00	$9,000.00	60,983
3/27/2019	V Bryan Lawlis	Director	Sell	2,150	$89.76	$192,984.00	21,310
3/25/2019	George Eric Davis	EVP	Sell	3,363	$87.86	$295,473.18	75,253
3/25/2019	Henry J Fuchs	Insider	Sell	5,932	$87.86	$521,185.52	130,468
3/25/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$87.86	$351,440.00	323,211
3/21/2019	Jeffrey Robert Ajer	EVP	Sell	4,519	$89.98	$406,619.62	56,659
3/19/2019	Jeffrey Robert Ajer	EVP	Sell	3,728	$93.07	$346,964.96	59,248
3/18/2019	Henry J Fuchs	Insider	Sell	9,597	$94.09	$902,981.73	133,061
3/15/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$94.40	$377,600.00	300,558
3/12/2019	Jean Jacques Bienaime	CEO	Sell	9,000	$90.06	$810,540.00	333,701
3/7/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$90.78	$363,120.00	332,701
3/4/2019	Henry J Fuchs	Insider	Sell	2,196	$95.00	$208,620.00	142,504
2/27/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$91.78	$367,120.00	292,290
2/21/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$90.12	$270,360.00	291,290
2/14/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$95.20	$380,800.00	292,290
2/5/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$98.63	$394,520.00	292,290
1/22/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$96.82	$290,460.00	291,290
1/14/2019	Jean Jacques Bienaime	CEO	Sell	4,000	$93.79	$375,160.00	292,290
1/10/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$90.55	$271,650.00	291,290
1/7/2019	Jean Jacques Bienaime	CEO	Sell	3,000	$87.58	$262,740.00	291,290
12/28/2018	Jean Jacques Bienaime	CEO	Sell	3,000	$84.04	$252,120.00
12/28/2018	Jean Jacques Bienaime	CEO	Sell	3,000	$84.04	$252,120.00	291,290
12/27/2018	V Bryan Lawlis	Director	Sell	2,150	$82.53	$177,439.50	21,310
12/26/2018	Jean Jacques Bienaime	CEO	Sell	4,000	$80.50	$322,000.00	292,290
12/14/2018	Jean Jacques Bienaime	CEO	Sell	2,000	$92.64	$185,280.00	290,290
12/12/2018	Jean Jacques Bienaime	CEO	Sell	2,000	$93.12	$186,240.00	290,290
11/14/2018	Jeffrey Robert Ajer	EVP	Sell	9,000	$92.15	$829,350.00	58,135
11/1/2018	Jean Jacques Bienaime	CEO	Sell	4,000	$92.55	$370,200.00	292,290

Insider Buying at BioMarin Pharmaceutical?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BioMarin Pharmaceutical and related companies.

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

94.44% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioMarin Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/22/2021	D.B. Root & Company LLC	7,729	$0.60M	0.2%	-16.4%	0.004%
10/22/2021	Strs Ohio	20,452	$1.58M	0.0%	-3.4%	0.011%
10/22/2021	DekaBank Deutsche Girozentrale	290,502	$22.33M	0.1%	+5.2%	0.158%
10/20/2021	Crumly & Associates Inc.	4,135	$0.32M	0.1%	-38.8%	0.002%
10/20/2021	Robeco Institutional Asset Management B.V.	2,994	$0.23M	0.0%	-63.3%	0.002%
10/19/2021	Kestra Advisory Services LLC	3,971	$0.31M	0.0%	+8.2%	0.002%
10/19/2021	Assenagon Asset Management S.A.	14,553	$1.13M	0.0%	N/A	0.008%
10/19/2021	Frontier Capital Management Co. LLC	497,530	$38.45M	0.3%	-17.9%	0.271%
10/18/2021	Raymond James Trust N.A.	3,657	$0.28M	0.0%	+6.9%	0.002%
10/18/2021	Exchange Traded Concepts LLC	31,747	$2.45M	0.1%	+1.7%	0.017%
10/18/2021	Nisa Investment Advisors LLC	20,717	$1.60M	0.0%	-1.0%	0.011%
10/18/2021	CMH Wealth Management LLC	37,661	$2.91M	1.0%	+4.8%	0.021%
10/15/2021	AdvisorNet Financial Inc	6,774	$0.52M	0.0%	+11.8%	0.004%
10/15/2021	DNB Asset Management AS	146,246	$11.30M	0.1%	+17.6%	0.080%
10/14/2021	Private Advisor Group LLC	4,185	$0.32M	0.0%	N/A	0.002%
10/14/2021	Manning & Napier Group LLC	1,742,981	$134.71M	1.2%	+0.9%	0.951%
10/13/2021	Scout Investments Inc.	420,317	$32.49M	0.5%	-32.0%	0.229%
10/12/2021	Altfest L J & Co. Inc.	3,557	$0.28M	0.1%	-31.8%	0.002%
10/12/2021	Arden Trust Co	3,863	$0.30M	0.1%	-4.0%	0.002%
10/12/2021	Stonnington Group LLC	5,800	$0.45M	0.1%	N/A	0.003%
10/12/2021	Rothschild Investment Corp IL	14,073	$1.09M	0.1%	-2.1%	0.008%
10/8/2021	Inspirion Wealth Advisors LLC	5,655	$0.44M	0.1%	+10.9%	0.003%
10/8/2021	Veriti Management LLC	3,828	$0.30M	0.0%	+29.6%	0.002%
10/7/2021	Berman Capital Advisors LLC	936	$71K	0.0%	+59.2%	0.001%
9/7/2021	Newbridge Financial Services Group Inc.	538	$45K	0.0%	+1,315.8%	0.000%
9/3/2021	Parametric Portfolio Associates LLC	213,604	$17.82M	0.0%	+1.6%	0.116%
8/30/2021	B. Metzler seel. Sohn & Co. Holding AG	8,981	$0.75M	0.0%	+8.4%	0.005%
8/30/2021	Integral Health Asset Management LLC	25,000	$2.09M	0.6%	-51.9%	0.014%
8/26/2021	Y Intercept Hong Kong Ltd	21,479	$1.79M	0.5%	N/A	0.012%
8/26/2021	Comerica Bank	24,576	$1.84M	0.0%	-6.9%	0.013%
8/25/2021	Marshall Wace LLP	40,951	$3.42M	0.0%	N/A	0.022%
8/25/2021	Marshall Wace North America L.P.	33,833	$2.82M	0.0%	N/A	0.018%
8/24/2021	Mariner LLC	15,977	$1.33M	0.0%	-4.2%	0.009%
8/19/2021	Advisor Resource Council	3,925	$0.33M	0.0%	N/A	0.002%
8/17/2021	Walleye Capital LLC	3,560	$0.30M	0.0%	N/A	0.002%
8/17/2021	Weiss Multi Strategy Advisers LLC	19,055	$1.59M	0.0%	+3.7%	0.010%
8/17/2021	Itau Unibanco Holding S.A.	408	$34K	0.0%	N/A	0.000%
8/17/2021	Beacon Pointe Advisors LLC	7,422	$0.62M	0.0%	N/A	0.004%
8/17/2021	Marathon Capital Management	2,500	$0.21M	0.0%	N/A	0.001%
8/17/2021	Maverick Capital Ltd.	6,480	$0.54M	0.0%	N/A	0.004%
8/17/2021	Metropolitan Life Insurance Co NY	3,773	$0.32M	0.0%	+31,341.7%	0.002%
8/17/2021	Millennium Management LLC	40,936	$3.42M	0.0%	-83.3%	0.022%
8/17/2021	Price T Rowe Associates Inc. MD	1,660,316	$138.54M	0.0%	-13.1%	0.906%
8/17/2021	Prudential Financial Inc.	10,628	$0.89M	0.0%	-2.1%	0.006%
8/17/2021	Paloma Partners Management Co	11,727	$0.98M	0.0%	-21.7%	0.006%
8/17/2021	Canada Pension Plan Investment Board	138,546	$11.56M	0.0%	-33.6%	0.076%
8/16/2021	Squarepoint Ops LLC	88,748	$7.41M	0.0%	-29.6%	0.048%
8/16/2021	AQR Capital Management LLC	10,352	$0.86M	0.0%	+40.8%	0.006%
8/16/2021	Amalgamated Bank	21,055	$1.76M	0.0%	+139.0%	0.011%
8/16/2021	FORA Capital LLC	16,030	$1.34M	0.2%	N/A	0.009%
8/16/2021	PDT Partners LLC	9,323	$0.78M	0.1%	N/A	0.005%
8/16/2021	Point72 Asset Management L.P.	366,500	$30.58M	0.1%	+42.9%	0.200%
8/16/2021	Cubist Systematic Strategies LLC	118,016	$9.85M	0.1%	+52.1%	0.064%
8/16/2021	Corient Capital Partners LLC	2,613	$0.22M	0.0%	N/A	0.001%
8/16/2021	California State Teachers Retirement System	319,775	$26.68M	0.0%	-6.1%	0.174%
8/16/2021	Melqart Asset Management UK Ltd	450,800	$37.62M	1.7%	+37.5%	0.246%
8/16/2021	Palo Alto Investors LP	2,212,950	$184.65M	10.2%	+0.3%	1.207%
8/16/2021	First Trust Advisors LP	1,215,874	$101.45M	0.1%	+7.6%	0.663%
8/16/2021	Public Employees Retirement System of Ohio	105,076	$8.77M	0.0%	+6.5%	0.057%
8/16/2021	Capital International Investors	548,043	$45.73M	0.0%	+0.2%	0.299%
8/16/2021	Tudor Investment Corp Et Al	2,814	$0.24M	0.0%	N/A	0.002%
8/16/2021	Schonfeld Strategic Advisors LLC	12,299	$1.03M	0.0%	N/A	0.007%
8/16/2021	Echo Street Capital Management LLC	5,009	$0.42M	0.0%	+52.8%	0.003%
8/16/2021	Charles Schwab Investment Management Inc.	616,320	$51.43M	0.0%	+6.0%	0.336%
8/16/2021	Andra AP fonden	104,900	$8.75M	0.2%	+17.7%	0.057%
8/16/2021	Freestone Capital Holdings LLC	9,244	$0.77M	0.0%	-3.2%	0.005%
8/16/2021	CIBC Asset Management Inc	33,308	$2.78M	0.0%	+11.7%	0.018%
8/16/2021	Nuveen Asset Management LLC	983,016	$82.02M	0.0%	-31.0%	0.536%
8/16/2021	Federated Hermes Inc.	5,190	$0.43M	0.0%	+14.8%	0.003%
8/16/2021	CIBC Private Wealth Group LLC	62,270	$5.20M	0.0%	+0.3%	0.034%
8/16/2021	Capula Management Ltd	2,950	$0.25M	0.0%	N/A	0.002%
8/16/2021	Dodge & Cox	14,102,097	$1.18B	0.8%	+19.0%	7.691%
8/16/2021	Marshall Wace LLP	40,951	$3.42M	0.0%	N/A	0.022%
8/16/2021	MML Investors Services LLC	13,420	$1.12M	0.0%	+22.4%	0.007%
8/16/2021	Tocqueville Asset Management L.P.	247,085	$20.62M	0.3%	+4.7%	0.135%
8/16/2021	Allianz Asset Management GmbH	54,117	$4.52M	0.0%	-99.9%	0.030%
8/13/2021	Renaissance Technologies LLC	289,971	$24.20M	0.0%	-20.7%	0.158%
8/13/2021	Steward Partners Investment Advisory LLC	566	$47K	0.0%	-32.3%	0.000%
8/13/2021	Northern Trust Corp	1,284,445	$107.18M	0.0%	+5.7%	0.701%
8/13/2021	Gabelli Funds LLC	33,920	$2.83M	0.0%	-2.2%	0.018%
8/13/2021	Caisse DE Depot ET Placement DU Quebec	5,029	$0.42M	0.0%	N/A	0.003%
8/13/2021	United Capital Financial Advisers LLC	15,175	$1.27M	0.0%	-35.9%	0.008%
8/13/2021	Laurion Capital Management LP	379,356	$31.65M	0.2%	+0.9%	0.207%
8/13/2021	Integral Health Asset Management LLC	50,000	$4.17M	0.6%	-3.8%	0.027%
8/13/2021	Ossiam	3,057	$0.24M	0.0%	+108.1%	0.002%
8/13/2021	Natixis	1,212,590	$101.18M	0.4%	+5.0%	0.661%
8/13/2021	Covington Capital Management	500	$42K	0.0%	+142.7%	0.000%
8/13/2021	APG Asset Management N.V.	150,832	$10.61M	0.0%	-72.6%	0.082%
8/13/2021	180 Wealth Advisors LLC	5,002	$0.39M	0.1%	+30.1%	0.003%
8/13/2021	IMA Wealth Inc.	32,456	$2.71M	0.6%	-1.3%	0.018%
8/13/2021	Waycross Partners LLC	2,700	$1.29M	0.0%	-41.3%	0.001%
8/13/2021	California Public Employees Retirement System	1,296,440	$108.18M	0.1%	+40.5%	0.707%
8/13/2021	Clearbridge Investments LLC	5,071,303	$423.15M	0.3%	+1.3%	2.766%
8/13/2021	LPL Financial LLC	64,667	$5.40M	0.0%	-11.1%	0.035%
8/13/2021	Parkwood LLC	3,448	$0.29M	0.0%	-24.4%	0.002%
8/13/2021	Franklin Resources Inc.	471,887	$39.38M	0.0%	+9.7%	0.257%
8/13/2021	Stifel Financial Corp	162,594	$13.57M	0.0%	-0.1%	0.089%
8/13/2021	Bridgewater Associates LP	23,181	$1.93M	0.0%	+72.5%	0.013%
8/13/2021	Nippon Life Global Investors Americas Inc.	213,180	$17.79M	0.9%	-3.9%	0.116%
8/13/2021	Toronto Dominion Bank	24,540	$2.05M	0.0%	-99.4%	0.013%

Data available starting January 2016

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Today's Range

Now: $73.74

$73.28

$74.80

50 Day Range

MA: $78.08

$73.92

$85.15

52 Week Range

Now: $73.74

$71.65

$92.57

Volume

1,026,153 shs

Average Volume

1,122,926 shs

Market Capitalization

$13.52 billion

P/E Ratio

17.19

Dividend Yield

N/A

Beta

0.53

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?: BioMarin Pharmaceutical's top insider shareholders include:
Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Richard A Meier (Director)
George Eric Davis (EVP)
Jeffrey Robert Ajer (EVP)
Michael G Grey (Director)
Brian Mueller (CFO)
David E I Pyott (Director)
V Bryan Lawlis (Director)
Willard H Dere (Director)
Who are the major institutional investors of BioMarin Pharmaceutical?: BioMarin Pharmaceutical's top institutional investors include:
Manning & Napier Group LLC — 0.95%
Frontier Capital Management Co. LLC — 0.27%
Scout Investments Inc. — 0.23%
DekaBank Deutsche Girozentrale — 0.16%
DNB Asset Management AS — 0.08%
CMH Wealth Management LLC — 0.02%
Which major investors are selling BioMarin Pharmaceutical stock?: During the previous quarter, BMRN stock was sold by these institutional investors:
Scout Investments Inc.
Frontier Capital Management Co. LLC
Robeco Institutional Asset Management B.V.
Crumly & Associates Inc.
Altfest L J & Co. Inc.
D.B. Root & Company LLC
Strs Ohio
SpiderRock Advisors LLC
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
Jean Jacques Bienaime (CEO)
Henry J Fuchs (Insider)
Richard A Meier (Director)
George Eric Davis (EVP)
Jeffrey Robert Ajer (EVP)
Michael G Grey (Director)
Which major investors are buying BioMarin Pharmaceutical stock?: During the last quarter, BMRN stock was bought by institutional investors including:
DNB Asset Management AS
Manning & Napier Group LLC
Assenagon Asset Management S.A.
DekaBank Deutsche Girozentrale
Stonnington Group LLC
Private Advisor Group LLC
CMH Wealth Management LLC
Veriti Management LLC

Learn to Customize Your Own Options Trading Strategy

From RJO Futures | Ad

Download your FREE Options Strategy Guide Today!

BMRN Insider Trading (BioMarin Pharmaceutical)

BioMarin Pharmaceutical Insider Trading History Chart

BioMarin Pharmaceutical Share Price & Price History

BioMarin Pharmaceutical Insider Trading History

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

Institutional Buying and Selling by Quarter

BioMarin Pharmaceutical Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

Who are the major institutional investors of BioMarin Pharmaceutical?

Which major investors are selling BioMarin Pharmaceutical stock?

Which major investors are buying BioMarin Pharmaceutical stock?